123 related articles for article (PubMed ID: 36037658)
1. miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia.
Hadi N; Namazi F; Ketabchi F; Khosravian F; Nateghi B; Talebi A; Baghi M; Mianesaz H; Zare F; Salehi M
Pathol Res Pract; 2022 Oct; 238():154077. PubMed ID: 36037658
[TBL] [Abstract][Full Text] [Related]
2. miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study.
Duroux-Richard I; Gagez AL; Alaterre E; Letestu R; Khalifa O; Jorgensen C; Leprêtre S; Tchernonog E; Moreaux J; Cartron G; Apparailly F
Front Immunol; 2022; 13():983771. PubMed ID: 36325355
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
[TBL] [Abstract][Full Text] [Related]
5. Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia.
Ahmadvand M; Eskandari M; Khakpour G; Pashaiefar H; Manoochehrabadi S; Yaghmaie M; Montazer-Zohour M; Naghavi A
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868841
[No Abstract] [Full Text] [Related]
6. Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients.
Raeisi F; Mahmoudi E; Dehghani-Samani M; Hosseini SSE; Ghahfarrokhi AM; Arshi A; Forghanparast K; Ghazanfari S
Mol Ther Oncolytics; 2020 Mar; 16():230-237. PubMed ID: 32123723
[TBL] [Abstract][Full Text] [Related]
7. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
8. Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study.
Hadi N; Seifati SM; Nateghi B; Ravaghi P; Khosravian F; Namazi F; Fotouhi Firouzabad M; Shaygannejad V; Salehi M
Cell J; 2022 Jul; 24(7):403-409. PubMed ID: 36043408
[TBL] [Abstract][Full Text] [Related]
9. Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Rep Biochem Mol Biol; 2021 Apr; 10(1):20-29. PubMed ID: 34277865
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
Fathullahzadeh S; Mirzaei H; Honardoost MA; Sahebkar A; Salehi M
Cancer Gene Ther; 2016 Oct; 23(10):327-332. PubMed ID: 27659777
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
12. Study of microRNA Profile as a Molecular Biomarker in Egyptian Chronic Lymphocytic Leukemia.
Farahat NMG; Elkaffash DMNED; Alghandour AH; Swelem RS; Abo El-Wafa RAH
Indian J Hematol Blood Transfus; 2019 Jan; 35(1):89-99. PubMed ID: 30828154
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
14. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.
Tili E; Michaille JJ; Luo Z; Volinia S; Rassenti LZ; Kipps TJ; Croce CM
Blood; 2012 Sep; 120(13):2631-8. PubMed ID: 22723551
[TBL] [Abstract][Full Text] [Related]
15. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
16. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
[TBL] [Abstract][Full Text] [Related]
17. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
20. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]